Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
New data show Lilly's EBGLYSSβ’ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis PR...
Lilly's Kisunlaβ’ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease PR Newswire INDIANAPOLIS, Sept. 24, 2024 Japan is the second major market where...
FDA Approves Lilly's EBGLYSSβ’ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis PR Newswire INDIANAPOLIS, Sept. 13, 2024 EBGLYSS provides a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 16.2 | 1.78453403833 | 907.8 | 939.86 | 903.46 | 3810115 | 919.26966391 | CS |
4 | -29.42 | -3.08573346479 | 953.42 | 969.6499 | 893 | 2676267 | 923.74997075 | CS |
12 | 13.44 | 1.47601476015 | 910.56 | 972.53 | 747.55 | 3220248 | 888.9174873 | CS |
26 | 153.73 | 19.9579368273 | 770.27 | 972.53 | 718.3 | 2905062 | 847.07170697 | CS |
52 | 371.47 | 67.2307386024 | 552.53 | 972.53 | 516.57 | 3061362 | 739.93292394 | CS |
156 | 693.39 | 300.676466762 | 230.61 | 972.53 | 220.2 | 2987831 | 477.65180416 | CS |
260 | 811.12 | 718.568391212 | 112.88 | 972.53 | 101.36 | 3257916 | 335.86916921 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.